Insider Selling: Teladoc Health Inc (NYSE:TDOC) Director Sells 740 Shares of Stock

Teladoc Health Inc (NYSE:TDOC) Director William H. Frist sold 740 shares of the company’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $203.06, for a total value of $150,264.40. Following the completion of the sale, the director now directly owns 6,158 shares in the company, valued at $1,250,443.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Teladoc Health stock traded up $3.49 during mid-day trading on Tuesday, reaching $190.84. 1,584,844 shares of the stock traded hands, compared to its average volume of 3,012,972. The stock has a market capitalization of $14.21 billion, a PE ratio of -141.36 and a beta of 0.44. The company has a debt-to-equity ratio of 0.45, a current ratio of 6.14 and a quick ratio of 6.14. Teladoc Health Inc has a 12-month low of $54.58 and a 12-month high of $208.63. The business’s 50-day moving average is $179.42 and its 200-day moving average is $137.26.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.05). The firm had revenue of $180.80 million for the quarter, compared to analysts’ expectations of $180.64 million. Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The firm’s revenue was up 40.6% compared to the same quarter last year. During the same quarter last year, the company posted ($0.43) EPS. Equities analysts anticipate that Teladoc Health Inc will post -1.12 EPS for the current fiscal year.

Several equities research analysts recently weighed in on TDOC shares. Credit Suisse Group upped their price target on Teladoc Health from $152.00 to $165.00 and gave the stock a “neutral” rating in a research note on Thursday, April 30th. Royal Bank of Canada reissued a “buy” rating on shares of Teladoc Health in a report on Tuesday. Deutsche Bank boosted their target price on Teladoc Health from $172.00 to $184.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Zacks Investment Research downgraded Teladoc Health from a “buy” rating to a “hold” rating and set a $171.00 target price on the stock. in a report on Thursday, May 28th. Finally, ValuEngine downgraded Teladoc Health from a “buy” rating to a “hold” rating in a report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $161.58.

A number of institutional investors have recently bought and sold shares of TDOC. Capital World Investors increased its position in Teladoc Health by 510.4% during the first quarter. Capital World Investors now owns 1,403,845 shares of the health services provider’s stock valued at $217,610,000 after acquiring an additional 1,173,845 shares during the last quarter. Norges Bank purchased a new stake in Teladoc Health in the fourth quarter worth about $51,004,000. Renaissance Technologies LLC purchased a new stake in Teladoc Health in the fourth quarter worth about $45,435,000. Fred Alger Management LLC increased its position in Teladoc Health by 405.7% in the first quarter. Fred Alger Management LLC now owns 625,931 shares of the health services provider’s stock worth $97,026,000 after buying an additional 502,144 shares in the last quarter. Finally, FDx Advisors Inc. increased its position in Teladoc Health by 16,754.5% in the first quarter. FDx Advisors Inc. now owns 406,531 shares of the health services provider’s stock worth $575,000 after buying an additional 404,119 shares in the last quarter. Institutional investors own 97.66% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: How is the discount rate different from the Federal Funds rate?

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.